Biostar Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Wang Ronghua, was filed 17 Jun 2011.
Biostar Pharmaceuticals, Inc.: what insiders have been doing
This page follows insider dealings at Biostar Pharmaceuticals, Inc. as filed with SEC (Form 4). Nothing new has been filed by managers of Biostar Pharmaceuticals, Inc. in twelve months, the latest record being from 17 June 2011.
Over the whole record (from 2011), the tally stands at 20 purchases and no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- -49.5%Entry US$22.89 · Close at T+365 US$11.55
- -65.5%Entry US$28.77 · Close at T+365 US$9.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 35,100 shares@ US$1.23Common StockSEC:0001185185-11-000888:0Canonical exit: 12 Sept 2011 (T+90)
- 14,350 shares@ US$1.19Common StockSEC:0001185185-11-000888:1Canonical exit: 13 Sept 2011 (T+90)
- 13,800 shares@ US$1.10Common StockSEC:0001185185-11-000888:2Canonical exit: 14 Sept 2011 (T+90)
- 19,700 shares@ US$1.21Common StockSEC:0001185185-11-000881:0Canonical exit: 8 Sept 2011 (T+90)
- 22,050 shares@ US$1.24Common StockSEC:0001185185-11-000881:1Canonical exit: 11 Sept 2011 (T+90)
- 34,600 shares@ US$1.26Common StockSEC:0001185185-11-000869:0Canonical exit: 6 Sept 2011 (T+90)
- 12,000 shares@ US$1.22Common StockSEC:0001185185-11-000869:1Canonical exit: 7 Sept 2011 (T+90)
- 10,300 shares@ US$1.24Common StockSEC:0001185185-11-000862:0Canonical exit: 4 Sept 2011 (T+90)
- 8,600 shares@ US$1.25Common StockSEC:0001185185-11-000862:1Canonical exit: 5 Sept 2011 (T+90)
- 6,900 shares@ US$1.27Common StockSEC:0001185185-11-000845:0Canonical exit: 1 Sept 2011 (T+90)
- 12,200 shares@ US$1.29Common StockSEC:0001185185-11-000838:0Canonical exit: 31 Aug 2011 (T+90)
- 1.09 shares@ US$1.30Common StockSEC:0001185185-11-000832:0Canonical exit: 30 Aug 2011 (T+90)
- 1,811 shares@ US$1.31Common StockSEC:0001185185-11-000832:1Canonical exit: 30 Aug 2011 (T+90)
- 2,500 shares@ US$1.32Common StockSEC:0001185185-11-000832:2Canonical exit: 30 Aug 2011 (T+90)
- 1,700 shares@ US$1.33Common StockSEC:0001185185-11-000832:3Canonical exit: 30 Aug 2011 (T+90)
- 1,700 shares@ US$1.35Common StockSEC:0001185185-11-000832:4Canonical exit: 30 Aug 2011 (T+90)
- 1,300 shares@ US$1.36Common StockSEC:0001185185-11-000832:5Canonical exit: 30 Aug 2011 (T+90)
- 200 shares@ US$1.37Common StockSEC:0001185185-11-000832:6Canonical exit: 30 Aug 2011 (T+90)
- 100 shares@ US$1.38Common StockSEC:0001185185-11-000832:7Canonical exit: 30 Aug 2011 (T+90)
- 30,000 shares@ US$1.41Common StockSEC:0001185185-11-000776:0Canonical exit: 17 Aug 2011 (T+90)
20 of 20 declarations
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc. is a company engaged in the manufacturing and distribution of pharmaceutical products in China. It primarily focuses on traditional Chinese medicines and natural health products.
